Skip to main content

Table 1 Numbers of samples showing immunoreaction to ER-α, ER-β, AR, and DAX-1

From: DAX-1 expression in human breast cancer: comparison with estrogen receptors ER-α, ER-β and androgen receptor status

 

BBD (n = 14)

CIS (n = 14)

Infiltrative ductal carcinoma (n = 24)

Infiltrative lobular carcinoma (n = 15)

Protein

N

C

N

C

N

C

N

C

ER-α

0 (0)

0 (0)

6 (42.86)

4 (28.57)

15 (62.5)

3 (12.5)

9 (60)

6 (40)

ER-β

0 (0)

0 (0)

0 (0)

4 (28.57)

0 (0)

9 (37.5)

0 (0)

9 (60)

AR

0 (0)

3 (21.4)

1 (7.15)

4 (28.57)

3 (12.5)

9 (37.5)

1 (6.66)

9 (60)

DAX-1

3 (21.42)

5 (35.72)

3 (21.43)

4 (28.57)

9 (37.5)

6 (25)

7 (46.66)

5 (33.33)

  1. Results in parentheses are percentages. AR, androgen receptor; BBD, benign breast diseases; C, cytoplasmic immunoreaction; CIS, in situ carcinomas; ER, estrogen receptor; N, nuclear immunostaining.